CEMIP and breast carcinoma: Previous studies have shown that KIAA1199, an oncogene that is transcriptionally induced by NF-κB proteins, promotes EGFR stability and contributes to the activation of NF-κB/EGFR signaling pathway crosstalk in breast cancer [43,44].